After a PhD in chemistry, marcel Kloosterman has worked since 1985 within DSM in various departments, ranging from R&D, business intelligence, marketing and sales, new business creation and venturing. In 2016, Marcel Kloosterman was delegated by DSM to become Director of Chemelot Ventures (regional fund of € 40 mln co-founded by i.a DSM and Rabo Bank). Targeting breakthrough private companies active in the areas of Life Sciences and Performance Materials, looking for equity financing. E.g. sustainable chemicals and smart materials, regenerative medicine and biomedical materials, drug delivery, diagnostics, analytics, innovative concepts in food and agro. Holding non-executive board seats in several European startups, acting as advisory board member and selection commitee member in several panels.